PHAT
#2554
Phathom Pharmaceuticals, Inc. - Common Stock
11.0 4 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.10%
Monthly Change
+3.08%
6 month change
-26.20%
Year Change
+27.63%
Previous Close
10.9 2
Open
11.0 4
Low
11.0 4
High
11.0 4
Volume
85
Financials
- Market Capitalization 880.51 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.32
Price to sales ratio
4.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2536 |  ANNX Annexon, Inc. - common stock | 5.55 USD | -1.42% | -12.74% | +19.61% | +120.24% | 909.33 M USD | ||
| 2551 |  GERN Geron Corporation - Common Stock | 1.38 USD | -2.82% | -6.76% | +20.00% | +7.81% | 885.30 M USD | ||
| 2562 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.92 USD | +0.12% | -0.53% | +3.05% | +17.91% | 872.28 M USD | ||
| 2571 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.67 USD | -1.37% | -6.88% | +22.71% | +230.19% | 853.79 M USD |
Frequently asked questions about Phathom Pharmaceuticals, Inc. - Common Stock
What is the Phathom Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) is 11.04. Over the past 24 hours, the stock has changed by +1.10%. Follow the PHAT chart for real-time price dynamics.
What is the stock ticker of Phathom Pharmaceuticals, Inc. - Common Stock?
Phathom Pharmaceuticals, Inc. - Common Stock trades under the ticker PHAT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Phathom Pharmaceuticals, Inc. - Common Stock stock going up?
PHAT has changed by -3.83% over the last week, +3.08% over the last month, and +27.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Phathom Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Phathom Pharmaceuticals, Inc. - Common Stock reported net income of -30.37 M for the last quarter. The previous quarter showed -21.15 M, which means net income changed by -43.60%.
How many employees does Phathom Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Phathom Pharmaceuticals, Inc. - Common Stock has 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Phathom Pharmaceuticals, Inc. - Common Stock EBITDA?
Phathom Pharmaceuticals, Inc. - Common Stock EBITDA is -15.37 M, and its EBITDA margin is -26.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Phathom Pharmaceuticals, Inc. - Common Stock stock?
You can buy Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Phathom Pharmaceuticals, Inc. - Common Stock stock?
Investing in Phathom Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHAT chart and related analysis on metatrader.com as part of your research.